Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report

BACKGROUND: Non-small-cell lung cancers (NSCLCs) harboring translocations in anaplastic lymphoma kinase (ALK) are highly sensitive to small-molecule ALK kinase inhibitors, such as crizotinib. CASE PRESENTATION: We describe a case of post-operative local recurrence of lung adenocarcinoma in an 81 yea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Res Notes
Main Authors: Fukuizumi, Aya, Miyanaga, Akihiko, Seike, Masahiro, Kato, Yasuhiro, Nakamichi, Shinji, Chubachi, Kumi, Matsumoto, Masaru, Noro, Rintaro, Minegishi, Yuji, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4415237/
https://ncbi.nlm.nih.gov/pubmed/25899913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1126-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados